0001209191-21-025759.txt : 20210406
0001209191-21-025759.hdr.sgml : 20210406
20210406200240
ACCESSION NUMBER: 0001209191-21-025759
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210401
FILED AS OF DATE: 20210406
DATE AS OF CHANGE: 20210406
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GUGGENHIME ANDREW
CENTRAL INDEX KEY: 0001230724
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39323
FILM NUMBER: 21810369
MAIL ADDRESS:
STREET 1: 3061 ZANKER RD
CITY: SAN JOSE
STATE: CA
ZIP: 95134
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vaxcyte, Inc.
CENTRAL INDEX KEY: 0001649094
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 464233385
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 353 HATCH DR
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
BUSINESS PHONE: 650-837-0111
MAIL ADDRESS:
STREET 1: 353 HATCH DR
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
FORMER COMPANY:
FORMER CONFORMED NAME: SutroVax, Inc.
DATE OF NAME CHANGE: 20150724
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-04-01
0
0001649094
Vaxcyte, Inc.
PCVX
0001230724
GUGGENHIME ANDREW
C/O VAXCYTE, INC.
353 HATCH DRIVE
FOSTER CITY
CA
94404
0
1
0
0
President and CFO
Stock Option (right to buy)
20.93
2021-04-01
4
A
0
145000
0.00
A
2031-03-31
Common Stock
145000
145000
D
1/48 of shares subject to the option vest on May 1, 2021, and 1/48 of the shares vest monthly thereafter.
/s/ Winston Macaraeg, Attorney-in-Fact
2021-04-06